LB PHARMACEUTICALS INC (LBRX): Ownership & Insider Activity
Hedge funds and institutional managers reporting a position in LBRX · Health Care. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.
Reported Holders
6
13F filers
Aggregate Value
$53.8M
Across holders
Last Price
$48.21
2026-08-24
Sector
Health Care
GICS
Quarterly fund activity3 increased2 reduced0 exited
| Manager⇅ | Type⇅ | Shares⇅ | Market Value▼ | % of Total⇅ | % of Portfolio⇅ | Action⇅ | QoQ Change⇅ | Quarter⇅ |
|---|---|---|---|---|---|---|---|---|
| BALYASNY ASSET MANAGEMENT LLC CIK 0001218710 | Hedge Fund | 921K | $29.9M | 55.5% | 0.0% | Reduced | $-72K | Q2 2026 |
| MILLENNIUM MANAGEMENT LLC CIK 0001273087 | Hedge Fund | 259K | $8.4M | 15.6% | 0.0% | Added | +$4.0M | Q2 2026 |
| CITADEL ADVISORS LLC CIK 0001423053 | Hedge Fund | 216K | $7.0M | 13.0% | 0.0% | Reduced | +$6.3M | Q2 2026 |
| BAKER BROS. ADVISORS LP CIK 0001263508 | Hedge Fund | 200K | $6.5M | 12.1% | 0.0% | Unchanged | +$0 | Q2 2026 |
| TWO SIGMA INVESTMENTS, LP CIK 0001179392 | Hedge Fund | 49K | $1.6M | 2.9% | 0.0% | Added | +$1.2M | Q2 2026 |
| SHAW D E & CO INC CIK 0001009207 | Hedge Fund | 14K | $439K | 0.8% | 0.0% | Added | — | Q2 2026 |
Reduced
Hedge Fund
$29.9M· 55.5% of total· 0.0% port· 921K sh· $-72K QoQ· Q2 2026
Added
Hedge Fund
$8.4M· 15.6% of total· 0.0% port· 259K sh· +$4.0M QoQ· Q2 2026
Reduced
Hedge Fund
$7.0M· 13.0% of total· 0.0% port· 216K sh· +$6.3M QoQ· Q2 2026
Unchanged
Hedge Fund
$6.5M· 12.1% of total· 0.0% port· 200K sh· +$0 QoQ· Q2 2026
Added
Hedge Fund
$1.6M· 2.9% of total· 0.0% port· 49K sh· +$1.2M QoQ· Q2 2026
Added
Hedge Fund
$439K· 0.8% of total· 0.0% port· 14K sh· — QoQ· Q2 2026
Loading recent insider activity…